We & Win Diversification Co., Ltd.
Taipei Exchange 4113.TWO
We & Win Diversification Co., Ltd. EBITDA Margin for the year ending December 31, 2023: -7.77%
We & Win Diversification Co., Ltd. EBITDA Margin is -7.77% for the year ending December 31, 2023, a 89.41% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
We & Win Diversification Co., Ltd. EBITDA Margin for the year ending December 31, 2022 was -73.42%, a -605.01% change year over year.
-
We & Win Diversification Co., Ltd. EBITDA Margin for the year ending December 31, 2021 was 14.54%, a 183.80% change year over year.
-
We & Win Diversification Co., Ltd. EBITDA Margin for the year ending December 31, 2020 was -17.35%, a -240.62% change year over year.
-
We & Win Diversification Co., Ltd. EBITDA Margin for the year ending December 31, 2019 was 12.34%.
Key data
| Date | EBITDA Margin | EBIT Margin | Depreciation and Amortization | EBIT |
|---|
Market news
Loading...
Taipei Exchange: 4113.TWO
| CEO | Mr. Yung-Yi Su |
| IPO Date | Dec. 31, 2007 |
| Location | |
| Headquarters | No. 185, Fuguo Road |
| Employees | 35 |
| Sector | Consumer Staples |
| Industries | |
Description
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung City, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email